Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$16.43 USD
+0.28 (1.70%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $16.42 -0.01 (-0.06%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum C VGM
Industry / Sector Report
Industry : REIT and Equity Trust - Other
Zacks Industry Rank
Top 37% (93 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.14 | 2.10 | 9.99 |
Current Quarter Estimate | 0.35 | 11.13 | 61.00 |
Year Ago Quarter Estimate | 0.34 | 2.93 | 54.84 |
Next Quarter Estimate | 0.35 | 11.36 | 63.00 |
Next Year Estimate | 1.48 | 67.43 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 5.26 | -2.80 | 15.67 |
Next Year | 5.71 | 3.70 | 11.34 |
Last 5 Years | -9.60 | -1.00 | 8.10 |
Next 5 Years | 4.60 | 7.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 12.08 | 51.86 |
Price/Book (MRQ) | 1.37 | 1.13 |
Price/Cash Flow (MRFY) | 19.30 | 12.23 |
Dividend Yield | 7.30% | 4.37% |
Net Profit Margin (TTM) | 7.58% | 18.30% |
Return on Equity (TTM) | 1.74% | 3.97% |
Debt to Equity (MRQ) | NA | 46.33 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.